These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20623619)

  • 1. Novel D3 dopamine receptor-preferring agonist D-264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and lactacystin.
    Li C; Biswas S; Li X; Dutta AK; Le W
    J Neurosci Res; 2010 Aug; 88(11):2513-23. PubMed ID: 20623619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease.
    Konieczny J; Jantas D; Lenda T; Domin H; Czarnecka A; Kuter K; Śmiałowska M; Lasoń W; Lorenc-Koci E
    Neurotox Res; 2014 Oct; 26(3):255-73. PubMed ID: 24842651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway.
    Gottschalk CG; Jana M; Roy A; Patel DR; Pahan K
    J Neurosci; 2021 Mar; 41(10):2287-2300. PubMed ID: 33514677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituent work via ameliorating the ubiquitin-proteasome system.
    Guo H; Shi F; Li M; Liu Q; Yu B; Hu L
    BMC Complement Altern Med; 2015 May; 15():151. PubMed ID: 25994206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease.
    Zhao YF; Zhang Q; Xi JY; Li YH; Ma CG; Xiao BG
    J Neurol Sci; 2015; 353(1-2):28-37. PubMed ID: 25908255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    Chen Y; Ni YY; Liu J; Lu JW; Wang F; Wu XL; Gu MM; Lu ZY; Wang ZG; Ren ZH
    BMC Neurosci; 2013 Jul; 14():76. PubMed ID: 23902361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease.
    Xu K; Xu YH; Chen JF; Schwarzschild MA
    Neuroscience; 2010 May; 167(2):475-81. PubMed ID: 20167258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection.
    Rombaut A; Jovancevic D; Wong RC; Nicol A; Brautaset R; Finkelstein DI; Nguyen CTO; Tribble JR; Williams PA
    Acta Neuropathol Commun; 2024 May; 12(1):79. PubMed ID: 38773545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B.
    Quinn LP; Crook B; Hows ME; Vidgeon-Hart M; Chapman H; Upton N; Medhurst AD; Virley DJ
    Br J Pharmacol; 2008 May; 154(1):226-33. PubMed ID: 18332857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pepper component 7-ethoxy-4-methylcoumarin, a novel dopamine D2 receptor agonist, ameliorates experimental Parkinson's disease in mice and Caenorhabditis elegans.
    Li H; Feng Y; Chen Z; Jiang X; Zhou Z; Yuan J; Li F; Zhang Y; Huang X; Fan S; Wu X; Huang C
    Pharmacol Res; 2021 Jan; 163():105220. PubMed ID: 33007422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson's disease.
    Chang E; Wang J
    Brain Behav; 2021 Aug; 11(8):e2251. PubMed ID: 34132500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Administration of Silybin Protects Against MPTP-Induced Neurotoxicity by Reducing Pro-inflammatory Cytokines and Preserving BDNF Levels in Mice.
    Ramírez-Carreto RJ; Zaldívar-Machorro VJ; Pérez-Ramírez DJ; Rodríguez-López BE; Meza C; García E; Santamaría A; Chavarría A
    Mol Neurobiol; 2023 Dec; 60(12):6774-6788. PubMed ID: 37480498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effects of repetitive transcranial magnetic stimulation with different high frequencies on motor functions in MPTP/probenecid induced Parkinsonism mouse models.
    Lyu Z; Xiao G; Xie D; Huang D; Chen Y; Wu C; Lai Y; Song Z; Huang L; Ming H; Jiang Y; Wang J; Chen R; Luo W
    Brain Behav; 2024 Jul; 14(7):e3605. PubMed ID: 38956819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pinostrobin mitigates neurodegeneration through an up-regulation of antioxidants and GDNF in a rat model of Parkinson's disease.
    Kongsui R; Promsrisuk T; Klimaschewski L; Sriraksa N; Jittiwat J; Thongrong S
    F1000Res; 2023; 12():846. PubMed ID: 38434672
    [No Abstract]   [Full Text] [Related]  

  • 15. Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits.
    Carnicella S; Drui G; Boulet S; Carcenac C; Favier M; Duran T; Savasta M
    Transl Psychiatry; 2014 Jun; 4(6):e401. PubMed ID: 24937095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
    Anandhan A; Janakiraman U; Manivasagam T
    Neuroscience; 2012 Aug; 218():257-67. PubMed ID: 22634505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration.
    Pothakos K; Kurz MJ; Lau YS
    BMC Neurosci; 2009 Jan; 10():6. PubMed ID: 19154608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.
    Sonsalla PK; Coleman C; Wong LY; Harris SL; Richardson JR; Gadad BS; Li W; German DC
    Exp Neurol; 2013 Dec; 250():376-83. PubMed ID: 24184050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease.
    Kim SN; Doo AR; Park JY; Bae H; Chae Y; Shim I; Lee H; Moon W; Lee H; Park HJ
    PLoS One; 2011; 6(11):e27566. PubMed ID: 22132113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice.
    Gerecke KM; Jiao Y; Pagala V; Smeyne RJ
    PLoS One; 2012; 7(8):e43250. PubMed ID: 22912838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.